- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 379 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Drug Pipelines
- December 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- August 2019
- 488 Pages
Global
From €3802EUR$3,999USD£3,194GBP
- Report
- February 2024
- 468 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- June 2021
- 265 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- February 2022
- 112 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- October 2021
- 156 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- October 2023
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 143 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- November 2023
- 300 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- July 2024
- 88 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2024
- 118 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 108 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- November 2021
- 1165 Pages
Global
From €5704EUR$6,000USD£4,792GBP
- Report
- June 2022
- 297 Pages
Global
From €3285EUR$3,456USD£2,760GBP

The DNA Repair market within the context of Genomics is a rapidly growing field of research and development. It involves the study of how cells repair damaged DNA, which can be caused by environmental factors such as radiation, chemicals, and other agents. This research is important for understanding the mechanisms of genetic diseases, cancer, and aging. It also has implications for the development of new treatments and therapies.
The DNA Repair market is composed of a variety of companies, ranging from large pharmaceuticals to small biotechs. These companies are focused on developing new technologies and treatments for genetic diseases, cancer, and aging. Examples of companies in this market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Sangamo Therapeutics. Show Less Read more